Joshua Epstein

The molecular classification of multiple myeloma

Fenghuang Zhan, Yongsheng Huang, Simona Colla et al. · Blood · 2006 · 1.1K citations · Full text

Medicine, Molecular Biology, Oncology +14

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

John D. Shaughnessy, Fenghuang Zhan, Bart Burington et al. · Blood · 2006 · 916 citations

Life Sciences, Genetics, Molecular Biology +12

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

Brian G.M. Durie, Antje Hoering, Muneer H. Abidi et al. · The Lancet · 2016 · 888 citations

Medicine, Hematology, Oncology +16

IRF4 addiction in multiple myeloma

Arthur L. Shaffer, N. C. Tolga Emre, Laurence Lamy et al. · Nature · 2008 · 728 citations · Full text

Medicine, Cancer Biology, Oncology +11

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients

Bart Barlogie, Raman Desikan, Paul Eddlemon et al. · Blood · 2001 · 543 citations · Full text

Medicine, Hematology, Oncology +17